NeuroOne Medical Technologies Corporation (NMTC)

Market Cap	28.98M
Revenue (ttm)	5.76M
Net Income (ttm)	-6.60M
Shares Out	47.39M
EPS (ttm)	-0.23
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	241,739
Open	0.6190
Previous Close	0.6229
Day's Range	0.5860 - 0.6227
52-Week Range	0.3954 - 1.3900
Beta	0.65
Analysts	Strong Buy
Price Target	1.45 (+137.12%)
Earnings Date	May 13, 2025

About NMTC

NeuroOne Medical Technologies Corporation, a medical technology company, provides solutions for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording in the United States. The company also provides solutions for spinal cord stimulation, radio frequency and brain stimulation, drug delivery and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other pain-related neurological disorders. The company also foc...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2009
• Employees: 17
• Stock Exchange: NASDAQ
• Ticker Symbol: NMTC
• Website: https://nmtc1.com

Financial Performance

In 2024, NMTC's revenue was $3.45 million, an increase of 1.33% compared to the previous year's $3.41 million. Losses were -$12.32 million, 3.87% more than in 2023.

Analyst Forecast

According to one analyst, the rating for NMTC stock is "Strong Buy" and the 12-month stock price forecast is $1.45.

Price Target

$1.45

(137.12% upside)

Analyst Consensus: Strong Buy